The field of pediatric urology is rapidly moving towards evidence-based guideline and clinical quality benchmarks, though few exist at this time. There remains wide variability on outcomes reporting and clinical practice patterns on a local, regional and national scale. We plan to address this variability with weekly educational material designed to ensure quality care for patients with pediatric urologic conditions. To do this, we will utilize a combination of available national standards in conjunction with departmentally maintained quality databases, institutional quality metrics and ongoing review of current literature to identify areas of variability and provide targeted educational activities to address these issues. This will provide pediatric urology providers strategies for high quality care using the best available evidence.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Physicians , Physician Assistants, Nurses/Nurse Practitioners, Medical Assistants
At the conclusion of this activity, the learner will be able to:
- Describe the current known best practices of pediatric urology and identify gaps in evidence based medicine for this condition.
- Make a plan to incorporate best practices into routine clinical care.
Presenters: Alison T. Coren, MD
Children’s Hospital of Wisconsin
All persons in control of content have NO relevant financial relationships to disclose.
1. Malignant testicular germ cell tumors in post-pubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling
M. Cools1,*,†, K.P. Wolffenbuttel2,†, R. Hersmus3, B.B. Mendonca4, J. Kaprová3,5, S.L.S. Drop6, H. Stoop3, A.J.M. Gillis3, J.W. Oosterhuis3, E.M.F. Costa4, S. Domenice4, M.Y. Nishi4, L. Wunsch7, C.A. Quigley8, G. T’Sjoen9, and L.H.J. Looijenga3 (Human Reproduction and Embryology 2017)
2. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
Klaus-Peter Dieckmann, Prof1,2; Arlo Radtke, PhD3; Lajos Geczi, MD, PhD4; Cord Matthies, MD5; Petra Anheuser, MD2; Ulrike Eckardt, MD6; J¨ org Sommer, MD7; Friedemann Zengerling, MD8; Emanuela Trenti, MD9; Renate Pichler, PhD10; Hanjo Belz, MD11;
Stefan Zastrow, MD12; Alexander Winter, MD13; Sebastian Melchior, Prof14; Johannes Hammel, MD14; Jennifer Kranz, MD1; Marius Bolten, MD16; Susanne Krege, Prof17; Bj¨orn Haben, MD18; Wolfgang Loidl, MD19; Christian Guido Ruf, MD20; Gazanfer Belge, PhD3 Julia Heinzelbecker, MD21; Axel Heidenreich, Prof22; Jann Frederik Cremers, MD23; Christoph Oing, MD24; Thomas Hermanns, MD25; Christian Daniel Fankhauser, MD25; Silke Gillessen, MD26; Hermann Reichegger, MD26; Richard Cathomas, MD27; Martin Pichler, Prof28; Marcus Hentrich, MD29; Klaus Eredics, MD30; Anja Lorch, Prof31; Christian Wu¨ lfing, Prof1; Sven Peine, MD24; Werner Wosniok, PhD3 Bokemeyer, Prof24; (JCO 2019)
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.